The Roles of DEA and FDA in the Cannabis Legalization Process
Listen now
Description
Stanley Jutkowitz, Senior Counsel with Seyfarth Shaw LLP discusses the recent DEA decision to reschedule cannabis from schedule one to schedule three, with potential less restrictive schedules. Stanley provided legal insights on the implications of this move, while highlighting the controversy surrounding cannabis legalization and rescheduling. We also explored the roles of DEA and FDA in the legalization process, emphasizing the complexity of the legal landscape with multiple agencies involved and conflicting treaty obligations and federal laws. We also discussed regulatory challenges and legal implications of cannabis, including the distinction between hemp and marijuana, taxation and decriminalization, and the current state of legalization and regulation in the US. Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy
More Episodes
Josh Lamb | Co-Founder/CEO of High Rewards discusses the launch of HighRewards, an app that rewards cannabis consumers for checking in at dispensaries, uploading receipts, and completing tasks. He also discussed the concept of rewards programs that allow users to monetize their everyday...
Published 06/24/24
Published 06/24/24
In this episode of Grassroots Marketing, we interview Dan Mondello, CEO and Co-Founder of Rank Really High, about the transformative potential of the Joint E-commerce Platform for the cannabis industry. Dan highlights how this seamless and integrated solution outperforms traditional methods like...
Published 06/17/24